Ana M. Rivas-Grajales, MD, MSc

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Ana Maria Rivas-Grajales is a neuropsychiatrist and Assistant Professor in the Department of Psychiatry at Boston University Chobanian & Avedisian School of Medicine. She serves as Director of Neuropsychiatry and Neuromodulation and as Director of the Transcranial Magnetic Stimulation (TMS) Clinic at Boston Medical Center, where she provides specialized care for patients with major depressive disorder.

Dr. Rivas-Grajales completed her residency training in psychiatry at Baylor College of Medicine, followed by a clinical fellowship in Behavioral Neurology and Neuropsychiatry at Massachusetts General Hospital. Her clinical expertise includes the neuropsychiatric complications of movement disorders, dementia, epilepsy, and functional neurological disorder, as well as psychiatric presurgical evaluations for patients undergoing surgical or device-based interventions for epilepsy and movement disorders.

Her research focuses on elucidating the mechanisms of action of neuromodulation therapies for treatment-resistant depression and on identifying clinical and neuroimaging biomarkers of rapid-acting antidepressant treatments.

Publications

  • Published 12/23/2025

    Rivas-Grajales AM, Mouradian P, Papadimitriou G, Lee E, Kubicki M, Makris N, Camprodon JA. Electroconvulsive therapy is associated with a decrease in anhedonia and axial diffusivity in the medial forebrain bundle in major depressive disorder. J Affect Disord. 2026 Apr 15; 399:120890. PMID: 41448396.

    Read at: PubMed

  • Published 1/10/2025

    Rivas-Grajales AM, Han SC, Wang R, Greenstein P, Shih LC. L266V MAPT Gene Mutation Associated With Frontotemporal Dementia, Progressive Supranuclear Palsy, and Corticobasal Syndrome. J Neuropsychiatry Clin Neurosci. 2025; 37(3):274-278. PMID: 39789940.

    Read at: PubMed

  • Published 7/31/2024

    Rivas JC, Galindo-A J, Zambrano LF, Miranda-B CA, Ramírez SM, Rivas-Grajales AM, Hernández-Carrillo M, Rincón EA, Perafán PE, Gómez-Mesa JE. Risk of corrected QT interval prolongation in patients receiving antipsychotics. Int Clin Psychopharmacol. 2025 Jul 01; 40(4):207-213. PMID: 39082114.

    Read at: PubMed

  • Published 12/19/2023

    Tanev KS, Camprodon JA, Caplan DN, Dickerson BC, Chemali Z, Eldaief MC, Kim DD, Josephy-Hernandez SE, Kritzer MD, Moo LR, Newhouse A, Perez DL, Ramirez Gomez LA, Razafsha M, Rivas-Grajales AM, Scharf JM, Schmahmann JD, Sherman JC. Telemedicine-Based Cognitive Examinations During COVID-19 and Beyond: Perspective of the Massachusetts General Hospital Behavioral Neurology & Neuropsychiatry Group. J Neuropsychiatry Clin Neurosci. 2024; 36(2):87-100. PMID: 38111331.

    Read at: PubMed

  • Published 5/1/2023

    Rivas-Grajales AM, Barbour T, Camprodon JA, Kritzer MD. The Impact of Sex Hormones on Transcranial Magnetic Stimulation Measures of Cortical Excitability: A Systematic Review and Considerations for Clinical Practice. Harv Rev Psychiatry. 2023 May-Jun 01; 31(3):114-123. PMID: 37171472.

    Read at: PubMed

View All 15 Publications:   View Full Profile in BUMC

Websites

Education

  • Universidad Del Valle, MD
  • University College London (UCL), MSc

View all profiles